APP is overexpressed with APLP in multiple cancers, including glioblastoma and breast, pancreatic, lung, colon, and prostate cancer, which is known to participate in the progression, proliferation, and migration of cancer cells [39]. This evidence concerns the gene APP and prostate cancer.